De Leo AB - Search Results

1

Development of dendritic cell-based genetic vaccines for cancer.

Tüting T, Zorina T, Ma DI, Wilson CC, De Cesare CM, De Leo AB, Lotze MT, Storkus WJ. Tüting T, et al. Among authors: de cesare cm, de leo ab. Adv Exp Med Biol. 1997;417:511-8. doi: 10.1007/978-1-4757-9966-8_84. Adv Exp Med Biol. 1997. PMID: 9286412 No abstract available.

2

DNA vaccines targeting dendritic cells for the immunotherapy of cancer.

Tüting T, Wilson CC, Martin DM, Baar J, DeLeo A, Lotze MT, Storkus WJ. Tüting T, et al. Adv Exp Med Biol. 1998;451:295-304. doi: 10.1007/978-1-4615-5357-1_46. Adv Exp Med Biol. 1998. PMID: 10026887 No abstract available.

3

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ. Zitvogel L, et al. J Exp Med. 1996 Jan 1;183(1):87-97. doi: 10.1084/jem.183.1.87. J Exp Med. 1996. PMID: 8551248 Free PMC article.

4

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.

Mayordomo JI, Loftus DJ, Sakamoto H, De Cesare CM, Appasamy PM, Lotze MT, Storkus WJ, Appella E, DeLeo AB. Mayordomo JI, et al. J Exp Med. 1996 Apr 1;183(4):1357-65. doi: 10.1084/jem.183.4.1357. J Exp Med. 1996. PMID: 8666894 Free PMC article.

5

Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines.

Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Garcia-Prats MD, DeLeo AB, Lotze MT. Mayordomo JI, et al. Stem Cells. 1997;15(2):94-103. doi: 10.1002/stem.150094. Stem Cells. 1997. PMID: 9090785 Review.

6

Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo.

Tüting T, DeLeo AB, Lotze MT, Storkus WJ. Tüting T, et al. Eur J Immunol. 1997 Oct;27(10):2702-7. doi: 10.1002/eji.1830271033. Eur J Immunol. 1997. PMID: 9368629

7

Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice.

Tüting T, Gambotto A, DeLeo A, Lotze MT, Robbins PD, Storkus WJ. Tüting T, et al. Cancer Gene Ther. 1999 Jan-Feb;6(1):73-80. doi: 10.1038/sj.cgt.7700020. Cancer Gene Ther. 1999. PMID: 10078966

8

Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.

Frassanito MA, Mayordomo JI, DeLeo RM, Storkus WJ, Lotze MT, DeLeo AB. Frassanito MA, et al. Cancer Res. 1995 Jan 1;55(1):124-8. Cancer Res. 1995. PMID: 7528638

9

Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cells.

Chikamatsu K, Nakano K, Storkus WJ, Appella E, Lotze MT, Whiteside TL, DeLeo AB. Chikamatsu K, et al. Clin Cancer Res. 1999 Jun;5(6):1281-8. Clin Cancer Res. 1999. PMID: 10389910

10

Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.

Tüting T, Gambotto A, Robbins PD, Storkus WJ, DeLeo AB. Tüting T, et al. Gene Ther. 1999 Apr;6(4):629-36. doi: 10.1038/sj.gt.3300859. Gene Ther. 1999. PMID: 10476222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters